Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02919969
Brief Title: Pembrolizumab in Metastatic Anal Cancer

First Submitted : September 2, 2016
First Submitted that Met QC Criteria : September 28, 2016
First Posted : September 30, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : May 12, 2021
Last Update Posted : May 14, 2021